Lawrence Korngut, University of Ottawa

Research

Clinical Trial Networks Networks Neuromuscular Disease Open Science Patient Partnerships Preclinical Research Resources Training And Education Translational Research

Latest papers

Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria
Pediatrics · 2021

All 1 publications

Latest funding

NMD4C: the neuromuscular network for Canada
CIHR · 2023 · Principal investigator
$1,000,000
BIND Study: Assessing the Indirect Socio-Economic Burden of Inherited Neuromuscular Diseases
CIHR · 2021 · Principal investigator
$449,030
NMD4C: An integrated research network for patients, scientists, and clinicians to improve outcomes and access to therapies for patients with neuromuscular disorders in Canada.
CIHR · 2019 · Co-investigator
$599,992

All 5 grants and awards

1 publications.

01

Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria

Pugliese M, Tingley K, Chow A, Pallone N, Smith M, Chakraborty P, Geraghty MT, Irwin JK, Mitchell JJ, Stockler S

Pediatrics202130 citations

DOI: 10.1542/peds.2020-037747

NMD4C: the neuromuscular network for Canada

Principal investigatorCIHR2023Network Gr. in Skin Health, Bone Health, and Muscular Dyst. - Muscular Dystrophy

Principal investigators: Lochmüller, Hanns; Osman, Homira; Brais, Bernard; Campbell, Craig Gordon N; Chang, Natasha C; Dowling, James; Gagnon, Cynthia; Gonorazky, Hernan D; Hodgkinson, Victoria; Karamchandani, Jason; Korngut, Lawrence W; Kothary, Rashmi K; Mah, Jean K; O'Connell, Colleen; Patten, Kessen; Rossi, Fabio M; Schellenberg, Kerri; Selby, Kathryn A; Warman Chardon, Jodi

Keywords: Clinical Trial Networks; Networks; Neuromuscular Disease; Open Science; Patient Partnerships; Preclinical Research Resources; Training And Education; Translational Research

$1,000,000

BIND Study: Assessing the Indirect Socio-Economic Burden of Inherited Neuromuscular Diseases

Principal investigatorCIHR2021Team Grant: Indirect Socio-Economic Burden of Inherited Diseases

Principal investigators: Warman Chardon, Jodi; Korngut, Lawrence W; Lochmüller, Hanns; Thavorn, Kednapa

Keywords: Indirect Costs

$449,030

NMD4C: An integrated research network for patients, scientists, and clinicians to improve outcomes and access to therapies for patients with neuromuscular disorders in Canada.

Co-investigatorCIHR2019Network Catalyst Grants - Muscular Dystrophy

Principal investigators: Lochmüller, Hanns; Buffone, Teresa; Dowling, James; Warman Chardon, Jodi

Keywords: Genomics; Knowledge Translation; Networks; Neuromuscular Disease; Patient Engagement; Translational Research

$599,992

An innovative registry-based trials platform to improve clinical care, outcomes, and health policy for children with treatable rare diseases

Co-investigatorCIHR2019Operating Grant: SPOR Innovative Clinical Trial Multi-Year Grant

Principal investigators: Potter, Elizabeth K; McCabe, Christopher; Smith, Maureen M; Binik, Ariella; Chakraborty, Pranesh K; Inbar-Feigenberg, Michal; Mitchell, John J; Offringa, Martin; Oskoui, Maryam; Stockler, Sylvia

Keywords: Comparative Effectiveness; Core Outcomes; Genetic Disease; Innovative Clinical Trial; Orphan Therapy; Patient Partnership; Patient-Oriented Outcomes; Pediatrics; Rare Disease; Registry-Based Randomized Trial

$2,754,009

Catalyzing registry-based randomized comparative effectiveness trials for inherited metabolic diseases in children: establishing a core outcome set and data collection tools

Co-investigatorCIHR2016Catalyst Grant: SPOR Innovative Clinical Trials (iCT)

Principal investigators: Potter, Elizabeth K; Clifford, Tammy J; Pallone, Nicole; Stockler, Sylvia

Keywords: Inherited Metabolic Disease; Pediatrics; Pragmatic Trial; Rare Disease; Registry; Registry-Based Randomized Trial

$100,000

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

School of Epidemiology and Public Health
Pharmacy
Pediatrics
Surgery
Epidemiology and Public Health
Pathology & Molecular Medicine
Other

Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Doug Coyle

School of Epidemiology and Public Health

1 shared papers, latest 2021

Murray Alexander Potter

Pathology & Molecular Medicine

1 shared papers, latest 2021

Jennifer MacKenzie

Pediatrics

1 shared papers, latest 2021

Monica Taljaard

School of Epidemiology and Public Health

1 shared papers, latest 2021

Brian Hutton

School of Epidemiology and Public Health

1 shared papers, latest 2021

Martin Offringa

Surgery

1 shared papers, latest 2021

Brian Hutton

Pharmacy

1 shared papers, latest 2021

Maureen Smith

Epidemiology and Public Health

1 shared papers, latest 2021

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Clinical Trial Networks Dear Professor Korngut, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Core Outcome Sets for Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Phenylketonuria" (2021), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "NMD4C: the neuromuscular network for Canada" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]